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IUGR : Intra uterine growth retardation
FGR : Fetal growth retardation
H/A : Head to abdomen ratio
F/A : Femur to abdomen ratio
AC : Abdominal  circumference 
HC : Head circumference
FL : Femur length 
AFV : Amniotic fluid volume
PFGR : Pathological fetal growth retardation
AEDV : Absent end diastolic velocity   
REDV : Reduced end diastolic velocity   
CLD : Chronic lung disease 




Fetal   growth  and  development  remains  one  of  the  most  complex  and 
fascinating  biologic  processes  known. The fetus has been described as the perfect 
parasite. Under  ideal  conditions  sufficient  amounts  of  maternal  nutrients are 
provided across a uteroplacental  circulation  that  functions   efficiently  to  meet  the 
demands of the growing fetus.  An appropriate  hormonal  and endocrine milieu for 
both the mother and the fetus enables optimal growth. This process is dependent on 
the  balanced  interactions  of  many  factors.  It  allows  normal  development  and 
maturation and ultimately a smooth transition form to extra uterine life. Metabolic 
shifts  occur in virtually all  maternal  nutrients during  pregnancy and the placenta 
and uteroplacental blood flow  plays a key role in the regulation  and  delivery  of 
these  fuels to  the fetus.
As  gestation  advances,  a  progressive  increase  in  uteroplacental  perfusion 
occurs.  A  persistently  larger  fraction  of  the  already  augmented  maternal  cardiac 
output is directed to the uteroplacental  circulation.  The increase  in  uterine blood 
flow parallels the increase in fetal weight as pregnancy  progresses.
If  the  balance  interaction  between  the  mother  and  the  fetus  is  disturbed 
it  leads  to  intrauterine growth  restriction.  Neonates  weighing  below  the  10th 
percentile   for   their   gestational   age  are   said  to   have  intrauterine   growth 
restriction. It  is  associated  with  high  perinatal  morbidity  and  mortality  as  the 
fetus  with  intrauterine growth  restriction  tolerates  labour  poorly and  antenatal 
diagnosis   of  intrauterine  growth  restriction  is  of  great   importance.  In such 
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foetuses  there  is  a significant  alteration  in  the  rate  of  blood  flow  and  it  acts  as 
a rate  limiting  factor  for  oxygen  and  glucose  consumption . 
There are various methods to diagnose intrauterine growth restriction. Clinical 
screening by fundal height measurement and maternal weight gain are used regularly 
during  prenatal  care  but  are  affected  significantly  by  extremes  of  amniotic  fluid 
volume and maternal body habitus.
Ultrasound can also be used to diagnose intra uterine growth restriction. The 
various  parameters  used  are  Biparietal  diameter,  Head  circumference,  abdominal 
circumference,  Transverse  cerebellar  diameter  and  sonographic  estimated  fetal 
weight.
Successful human placentation,  resulting in  the birth  of a healthy infant  at 
term, is dependent upon normal placental development. Uteroplacental bed perfusion 
increases in normal pregnancy and decrease in intra uterine growth restriction and 
pregnancy  induced  hypertension.  The  alteration  in  the  uterine  and  umbilical 
circulation precedes the onset of intrauterine growth restriction. Most cases of growth 
retardation are hemodynamically mediated at some point making Doppler technology 
the ideal diagnostic tool for this major perinatal problem. 
Foetuses with abnormal flow velocity waveforms have a higher incidence of 
perinatal  asphyxia  and  death  than  those  with  normal  flow  characterization.  Thus 
Doppler evaluation of the uterine and umbilical blood flow can be used to detect fetal 
jeopardy in fetus at risk for placental insufficiency. The placental villous dysfunction 
in  growth  restricted  foetuses  with  abnormally  low  umbilical  artery  blood  flow, 
indicated  by  absent  or  reverse  end  diastolic  flow,  is  characterised  by  reduced 
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elaboration of gas-exchanging peripheral villi, which increase the risk of chronic fetal 
hypoxia  and  acidosis.  Among  the  large  number  of  maternal  factors,  maternal 
hypertension is one of the most important factors in intrauterine growth retardation. 
Pregnancy  induced  hypertension   associated  placental  pathology  include  infarcts, 
retroplacental  haemorrhage,  accelerated  maturation,  fibromuscular  hyperplasia  and 
obliterative  end  arteritis  of  the  fetal  stem artery,  villous  edema,  stromal  fibrosis, 
increased  number  of  syncytial  knots,  cytotrophoblast  hyperplasia,  trophoblast 
basement  membrane  thickening,  deficiency  of  the  vasculo  syncytial  membrane, 
excessive fibrinoid necrosis, and acute atherosis in decidual vessels.
The  known  placental  pathology  of  an  IUGR  infant  includes  decrease  of 
placental growth, maternal vasculopathy, chronic villitis, increase perivillous fibrin, 
fetal  thrombotic arteriopathy and avascular villi  as its secondary feature, umbilical 
cord anomaly,  infarct, cytotrophoblast hyperplasia, basement membrane thickening, 
etc.  Histologic  examination  of  the  placentas  from  IUGR  fetuses  can  supplement 
clinical  knowledge  of  the  cause  of  IUGR.  The  present  study  was  undertaken  to 
investigate the pathologic findings regarding the placentas in IUGR foetuses and to 
correlate the results with Doppler findings.
As with many maternal and fetal conditions, careful evaluation of the placenta 
may aid in diagnosis of an underlying condition, a recurrent condition, chromosomal 
abnormalities, or systemic diseases. Only through the careful gross and microscopic 
pathologic examination of the placenta can an undiagnosed or suspected condition be 






Normal fetal growth involves hyperplasia and hypertrophy on a cellular level. 
Disturbance of fetal growth dynamics can lead to reduced cell number, cell size, or 
both, ultimately resulting in abnormal weight, body mass, or body proportion at birth. 
Neonates  weighing  below  the  10th percentile  for  their  gestational  age  are  said 
to  have  intrauterine  growth  restriction1. Next to prematurity, IUGR is the second 
leading  cause  of  perinatal  mortality2.  Compared  with  appropriately  grown 
counterparts, perinatal mortality rates in growth restricted neonates are 6 to 10 times 
greater; perinatal mortality rates as high as 120 per 1,000 for all cases of IUGR and 80 
per 1,000 after exclusion of anomalous infants have been reported3. In its most severe 
form the abnormal umbilical artery Doppler waveform is characterized by absent or 
reversed  end-diastolic  flow  velocity,  and  perinatal  mortality  in  this  group  of 
pregnancies  complicated by intrauterine growth restriction (IUGR) ranges between 
40% and 70%4. Incidence of IUGR is close to 10% of all births.  
CLASSIFICATION OF IUGR:
I. BASED ON PRESENCE OR ABSENCE OF SYMMETRY:
B. Type  I  /  Symmetric  FGR:  foetuses  that  are  symmetrically  small  and  have 
normal H/A and F/A ratios 
C. Type II / Asymmetric FGR: foetuses that  have an AC that is smaller than HC 
and FL resulting in abnormally  high H/A and F/A ratios 
D. Type III / Intermediate FGR: foetuses that are initially symmetric but become 
asymmetric later in the pregnancy
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II. BASED ON ORIGIN OF THE PROBLEM:
A. Intrinsic:  foetuses  those are  small  due  to  fetal  conditions  such as  viral 
infections or chromosomal abnormalities. 
B. Extrinsic:  growth failure is due to an element outside the fetus such as 
placental conditions or maternal diseases. 
C. Combined:  FGR  occurs  when  there  are  extrinsic  and  intrinsic  factors 
causing growth failure. 
D. Idiopathic: FGR occurs when the cause of fetal growth failure is unknown. 
III. ETIOLOGIES OF INTRAUTERINE GROWTH RESTRICTION5:
A. Maternal: cardio respiratory diseases, renal diseases, anaemia, acidosis, fever, drugs 
(diethylstilbestrol, anticancer drugs agents, narcotics), smoking, alcohol. 
B. Fetal:  Infections,  heart  disease,  malformations,  chromosomal  abnormalities, 
osteogenesis imperfecta. 
C. Placental:  abruptio  placentae,  placenta  previa,  thrombosis,  infarction, 
deciduitis, placentitis, vasculitis, edema, chorioamnionitis, placental cyst, 
chorangioma.
D. Uterine:  decreased  uteroplacental  blood  flow,  atheromatosis, 
arteriosclerosis  of  decidual  spiral  arteries,  connective  tissue  disorders, 
chronic  hypertension,  preeclampsia,  diabetes  mellitus,  fibromyoma, 
morphologic abnormalities.   
REGULATION OF FETAL GROWTH
Fetal  growth  is  regulated  at  multiple  levels  and  requires  successful 
development of the placental interface between maternal and fetal compartments. In 
the early first trimester, anchoring villi originating from the cytotrophoblast connect 
the  decidua  to  the  uterus  and  thereby  establish  placental  adherence.  This  allows 
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formation  of  vascular  connections  between  the  maternal  circulation  and  the 
intervillous  space so that  increasing  quantities  of  placental  secretory products  can 
reach the maternal circulation.
The villous trophoblast now becomes the primary placental site of maternal-
fetal exchange. By 16 weeks gestation, the maternal microvillous and fetal basal layer 
are only 4 microns apart, posing little resistance to passive diffusion. Elaboration of 
active transport mechanisms for three major nutrient classes (glucose, amino acids, 
and free fatty acids) and an increase in the villous surface area raise the capacity and 
efficiency of active transplacental transport. Extravillous cytotrophoblast invasion of 
the maternal spiral arteries results in progressive loss of the musculoelastic media, a 
process paralleled on the fetal  side by continuous villous vascular branching.  This 
results in significant reduction of blood flow resistance in the uterine and umbilical 
vessels,  converting both circulations  into  low-resistance,  high-capacitance  vascular 
beds.  The decrease in vascular  resistance is  related  to  two waves  of  angiogenesis 
within the placenta. The first is branching angiogenesis occurring at the end of the 
first and beginning of the second trimester, which increases the number of vascular 
branches.  The  second  wave  is  nonbranching  angiogenesis,  which  does  not  create 
additional branches but rather results in elongation of the existing placental vascular 
tree. This latter process occurs at the end of the second and beginning of the third 
trimester6. 
Owing to  these  developments,  a  minimum of  600 ml/min  of  the  maternal 
cardiac output reaches a placental exchange area of up to 12m2 at term1. In the fetal 
compartment,  this is matched with a blood flow volume of 200 to 300 ml/kg/min 
throughout gestation. This magnitude of maternal blood flow is necessary to ensure 
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maintenance of placental function that is energy intensive and consumes as much as 
40 percent of the oxygen and 70 percent of the glucose supplied. Optimal fetal growth 
and development depends on a magnitude of maternal nutrient and oxygen delivery to 
the uterus that leaves sufficient surplus for fetal substrate utilization.
PATHOPHYSIOLOGICAL CHANGES IN IUGR:
Maternal Impacts
Placental  dysfunction  affects  several  aspects  of  maternal  adaptation  to 
pregnancy. When trophoblast invasion remains confined to the decidual portion of the 
myometrium,  maternal  spiral  and  radial  arteries  fail  to  undergo  the  physiologic 
transformation into low resistance vessels, which is generally expected by 22 to 24 
weeks7,8. Normal and abnormal spiral artery adaptation can be detected with maternal 
uterine  artery  Doppler  studies.  Maternal  placental  floor  infarcts,  fetal  villous 
obliteration,  and  fibrosis  increase  placental  blood  flow  resistance,  producing 
maternal-fetal  placental  perfusion  mismatch  that  decreases  the  effective  exchange 
area9. With progressive vascular occlusion, fetoplacental flow resistance is increased 
throughout  the  vascular  bed  and eventually  metabolically  active  placental  mass  is 
reduced.
Fetal Impacts:
Metabolic  manifestations  occur  early  in  growth-restricted  fetuses.  With 
progression of placental insufficiency, nutrient deficits become universal and result in 
decreased fetal and placental size. When uterine oxygen delivery falls below a critical 
value (0.6 mmol/min/Kg fetal body weight in sheep), fetal oxygenation begins to fall 
and  is  eventually  accompanied  by  fetal  hypoglycaemia10.  The  initially  mild 
hypoglycaemia  results  in  a  blunted  fetal  pancreatic  insulin  response,  allowing 
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glycogenolysis from hepatic glycogen stores11. The minimal hepatic glycogen stores 
in the fetus are quickly depleted as glucose and lactate are preferentially diverted to 
the placenta. An increasing metabolic manifestations occur early in growth-restricted 
fetuses.  With  progression  of  placental  insufficiency,  nutrient  deficits  become 
universal  and  result  in  decreased  fetal  and  placental  size.  When  uterine  oxygen 
delivery falls below a critical value (0.6 mmol/min/Kg fetal body weight in sheep), 
fetal  oxygenation  begins  to  fall  and  is  eventually  accompanied  by  fetal 
hypoglycaemia10.  The  initially  mild  hypoglycaemia  results  in  a  blunted  fetal 
pancreatic insulin response, allowing glycogenolysis from hepatic glycogen stores11. 
The  minimal  hepatic  glycogen  stores  in  the  fetus  are  quickly  depleted  as 
glucose and lactate are preferentially diverted to the placenta. An increasing nutrient 
deficit leads to worsening fetal hypoglycaemia.  Limitation of amino acid transfer and 
breakdown  of  endogenous  muscle  protein  to  obtain  gluconeogenic  amino  acids 
depletes  branched-chain  and other  essential  amino  acids12.  Simultaneously,  lactate 
accumulates  owing  to  the  limited  capacity  for  oxidative  metabolism.  Placental 
transfer  of  fatty  acids  loses  its  selectivity  particularly  for  essential  fatty  acids. 
Reduced utilization leads to increased fetal free fatty acid and triglyceride levels with 
a  subsequent  failure  to  accumulate  adipose  stores.  In  this  setting  of  advancing 
malnutrition, cerebral and cardiac metabolism of lactate and ketones is up regulated to 
remove these accumulating products of anaerobic  metabolism13.  Acid-base balance 
can be maintained as long as acid production is met by sufficient buffering capacity of 
fetal  haemoglobin  and  an  equal  disposition  by  these  organs.  Thus,  metabolic 
compromise progresses from simple hypoglycaemia, hypoxemia, and decreased levels 
of  essential  amino  acids  to  overt  hypo  aminoacidemia,  hypercapnia, 
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hypertriglyceridemia,  and  hyperlacticemia.  The  lactate  production  is  exponentially 
correlated to the degree of acidemia that generally results from this metabolic state14.
Table 1
Metabolic Responses to Placental Insufficiency 
SUBSTRATE CHANGE




Significant decrease in branched-chain amino acids (valine, 
leucine, isoleucine) as well as lysine and serine. In contrast, 
hydroxyproline is elevated. The decrease in essential amino 
acids  is proportional to the degree of hypoxemia.
Elevated amniotic  fluid glycine-to-valine ratio.  Elevations  in 
amniotic fluid ammonia, with a significant positive correlation 
with the fetal ponderal index.
Fatty acids and
triglycerides
• Decrease  in  long-chain  polyunsaturated  fatty  acids 
(docosahexanoic  and  arachidonic  acids).  Decrease  in 
overall fattya cid transfer only with significant loss of 
placental substance.
• Hypertriglyceridemia due to decreased utilization
Oxygen and
CO2
• Degree of hypoxemia proportional to villous damage 
and correlates significantly with hypercapnia, acidemia 
and hypoglycemia and hyperlacticemia.
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In growth-restricted fetuses, declining function at all levels of the thyroid axis 
correlate to the degree of hypoxemia15.  Thyroid gland dysfunction may develop, as 
indicated by low levels of thyroxine and triiodothyronine despite elevated thyroid-
stimulating hormone levels.  In other instances,  central  underproduction of thyroid-
stimulating hormone may be responsible  for fetal  hypothyroidism16.  Finally,  down 
regulation of thyroid hormone receptors may limit the biologic activity of circulating 
thyroid hormones in specific target tissues such as the developing brain17.
Elevations in serum glucagon, adrenaline,  noradrenaline,  and stimulation of 
the  fetal  glucocorticoid  axis  have  immediate  effects  in  fetal  life  promoting  the 
mobilization of hepatic glycogen stores and peripheral glycogenolysis18.
HAEMATOLOGICAL RESPONSE:
Fetal hypoxemia is a trigger for erythropoietin release and stimulation of red 
blood cell production through both medullary and extramedullary sites resulting in 
polycythemia19.  Oxygen-carrying  capacity  and  the  buffering  capacity  are  thus 
increased  through  the  elevation  in  haemoglobin  count.  If  extramedullary 
haematopoiesis is increasingly induced by prolonged tissue hypoxemia or acidosis, 
the nucleated red blood cell count rises owing to the escape of these cells from these 
sites. In advanced placental insufficiency, more complex hematologic abnormalities 
supervene that may result from dysfunctional erythropoiesis, placental consumption, 
and vitamin and iron deficiency20. Subsequently, fetal anaemia and thrombocytopenia 
are observed, particularly in fetuses with marked elevation of placental blood flow 
resistance  and  evidence  of  intraplacental  thrombosis  suggesting  a  causative 
relationship21,22.  An increase in whole blood viscosity23, a decrease in red blood cell 
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membrane  fluidity24,  and  platelet  aggregation  may  be  important  precursors  for 
accelerating placental vascular occlusion and dysfunction.
CELLULAR AND HUMORAL LEVEL:
Decreases in immunoglobulin, absolute B-cell counts, total white blood cell 
counts, neutrophil,  monocyte and lymphocyte sub populations,  as well as selective 
suppression of T-helper and cytotoxic T cells  are related to the degree of acidemia.
DIAGNOSTIC TOOLS:
Obstetric  history:  predisposing  factors   maternal  age  <19yrs  or  >36yrs, 
grand multiparity, pre-pregnant maternal weight <45kgs, bleeding per vaginum > 28 
wks suggestive of placenta previa or abruption, previous history or family history of 
IUGR1.
MATERNAL HISTORY:
History  suggestive  of  chronic  hypertension,  preeclampsia,  chronic  renal 
disease,  diabetes  with  vascular  involvement,  cardiac  disease,  sickle  cell  anaemia, 
smoking, alcohol, living at high altitude predisposes to IUGR1.
CLINICAL SCREENING:
Poor maternal weight gain: poor maternal weight gain during pregnancy is a 
relatively insensitive sign of inadequate fetal growth, stationary or falling weight may 
suggest IUGR.
Poor maternal weight gain: 
Poor maternal weight gain during pregnancy is a relatively insensitive sign of 
inadequate fetal growth, stationary or falling weight may suggest IUGR .
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Symphyseal fundal height:
The maternal uterine fundus is objectively measured and charted during each 
antenatal  visit.  After 20 wks,  the normal  symphyseal  fundal height  in centimetres 
approximates the number of weeks of gestation. Sensitivity for detection of IUGR 
ranges from 60%-85%, and positive predictive values are 20% to 80%5.
Abdominal palpation:
Serial clinical examination to measure the relative growth of the uterus and its 
contents is the mostly used method. The range of error is 2 weeks in the I trimester 
and 4 weeks in the II and III trimester. Sensitivity is 44%1.
BIOCHEMICAL SCREENING:
Atleast four hormones or protein markers measured in the maternal sera early 
in the II trimester are associated with subsequent IUGR. These include estriol, human 
placental lactogen, hCG, and alpha fetoprotein. Clinically, maternal serum alpha feto 
protein  is  the  most  useful  as  a  marker  of  abnormal  placentation.  Most  studies 
conclude  that  a  single,  unexplained  elevated  value  increase  the  risk  of  growth 
restriction 5 to 10 fold5.
UTERINE ARTERY DOPPLER STUDIES
An early diastolic  notch in the uterine arteries  at  12 to 14 weeks suggests 
delayed  trophoblast  invasion,  whereas  persistence  of  “notching”  beyond  24  wks 
provides confirmatory evidence.  A uterine artery Doppler resistance profile  that  is 
high, persistently notched, or both, identifies women who are at risk for preeclampsia 
and IUGR. Sensitivity is 85%5.
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Fig 1: Persistance of early diastolic notch after 24 weeks 
identifies women at risk of IUGR
Fig 2 : Uterine Artery Normal
ULTRASONIC DIAGNOSIS:
Ultrasound biometry is the diagnostic tool of choice for documentation of fetal 
growth  disorders.  Once  the  gestational  age  is  assigned,  the  interpretation  of  an 
ultrasound  growth  study  is  based  upon  the  fetal  anatomic  survey,  amniotic  fluid 
volume,  percentile  rank of  fetal  size  measurements,  interval  growth since the  last 
study,  and  functional  assessment  of  the  placental  unit  with  Doppler  ultrasound 
(umbilical and uterine arteries).
Direct measurements:
Biparietal Diameter:
It’s a poor tool for the detection of IUGR. The majority of growth-restricted 
fetuses presenting with asymmetric growth restriction and delayed flattening of the 
cranial growth curve would be detected relatively late
Head Circumference: 
The  HC is  not  subject  to  the  same  extrinsic  variability  as  the  BPD.  The 
measurement  technique  is  important  because  calculated  HC  measurements  are 
systematically smaller than those directly measured. As a screening tool for IUGR, 
the HC poses a similar problem because the BPD in that two thirds of IUGR fetuses 
with asymmetric growth pattern would be detected late.
Abdominal Circumference:
The AC is the single best measurement for the detection of IUGR25 because it 
is  related  to  liver  size,  which  is  a  reflection  of  fetal  glycogen  storage.  The  most 
accurate  AC  is  the  smallest  directly  measured  circumference  obtained  in  a 
perpendicular plane of the upper abdomen at the level of the hepatic vein between 
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fetal respirations26. Sensitivity is 95% and specificity is 60%.positive predictive value 
is 21% and negative predictive value is 99%.
Femur Length:
FL is not affected in asymmetric IUGR. Sensitivity is 45% and specificity is 
97%.positive predictive value is 64% and negative predictive value is 94%.
Transverse cerebellar Diameter:
It  is  one  of  the  few  soft  tissue  measurements  that  correlate  well  with 
gestational  age27,  being  relatively  spared  from  the  effects  of  mild  to  moderate 
uteroplacental dysfunction. Whether its measurement offers any advantage over bony 
measurements in the assessment of compromised fetal growth is controversial28,29.
Estimated fetal weight:
Ultrasonic fetal  weight estimates are usually within 5-10% of the true fetal 
weight. Sensitivity is 89% and specificity is 88%. Positive predictive value is 45% 
and negative predictive value is 99% for the detection of FGR (Ott, 1997). The most 
commonly used formula to determine EFW and the most commonly used percentile 
distribution nomograms are Hadlock et al (1984, 1991).
Amniotic Fluid Index: 
This is measured with a four quadrant technique and is obtained by the sum of 
four deepest vertical pools in each quadrant. A relationship between oligohydramnios 
and  progressive  deterioration  of  arterial  and  venous  Doppler  studies  has  been 
documented  in  growth-restricted  fetuses  and  prolonged  pregnancies30.  Therefore, 
declining AFV is suggestive of ineffective downstream delivery of cardiac output, 
allowing  some  form  of  longitudinal  monitoring  even  in  the  absence  of  Doppler 
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studies.  The regulation of AFV by the late second and third trimester  is primarily 
dependent on fetal urine output, production of pulmonary fluid, and fetal swallowing. 
Placental dysfunction and fetal hypoxemia both may result in decreased perfusion of 
the fetal kidneys with subsequent oliguria and decreasing AFV31. Its a late sign of 
IUGR. Sensitivity is 83% and Specificity is 60%.
Table 2
 Incidence of IUGR in Oligohydramnios
Vertical pocket Incidence of IUGR
>2 cm 6%
1- 2 cm 20%
< 1 cm 39%
MEASUREMENT RATIOS:
Head to abdomen ratio (HC/AC):
This ratio compares the most preserved organ in the malnourished fetus, the 
brain, represented by the circumference of the fetal head, with the most compromised 
organ, the liver, represented by fetal AC. In a normally growing fetus HC/AC ratio 
compromised organ, the liver, represented by fetal AC. In a normally growing fetus 
HC/AC ratio exceeds 1.0 before 32 wks. It is approximately 1.0 at 32-34 wks. After 
34  wks  it  falls  below 1.0.  If  the  fetus  is  affected  by  asymmetric  IUGR,  the  HC 
remains larger. The HC/AC ratio is then elevated. In symmetric IUGR both the HC 
and AC are reduced and the ratio remains normal. Using this HC/AC ratio, 85% of 
IUGR foetuses are detected5.  
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Femur length to abdomen circumference (FL/AC):
This ratio remains constant after 20 wks. The normal value for this index is 
22±2. An upper limit of 23.5 has a sensitivity of 63.3% and a specificity of 90% for 
the diagnosis of FGR.
Fetal ponderal index (FPI):
FPI is gestational age independent and has a constant value throughout the 
second half of pregnancy. It is obtained by dividing the EFW by the third power of FL 
(vintzileos et al., 1986). Its normal value is 8.325 ± 2.5 (2 SD).An FPI of 7.0 / less 
should  be  considered  abnormal  and  suggestive  of  PFGR.  Sensitivity  is  55% and 
specificity  is  71%.positive  predictive  value  18% and  negative  predictive  value  is 
92%32.
DOPPLER STUDIES:  
The use  of  Doppler  for  the  evaluation  of  fetal  circulation  is  based  on the 
principle of change in frequency of a sound wave when it is reflected by a moving 
object. The role of Doppler velocimetry in the management of fetal growth restriction 
is unique because it serves as a diagnostic as well as a monitoring tool. Doppler flow 
velocity waveforms may be obtained from arterial and venous vascular beds in the 
fetus.
Umbilical artery Doppler:
It’s a powerful tool that allows to follow a sequence of fetal hemodynamic 
events  that  happens  in  response  to  placental  insufficiency.  Arterial  Doppler 
waveforms provide information on downstream vascular resistance,  which may be 
altered  owing  to  structural  changes  in  the  vasculature  or  regulatory  changes  in 
vascular tone. 
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The systolic/diastolic ratio, resistance index, and the pulsatility index are the 
three Doppler indices most widely used to analyze arterial blood flow resistance. An 
increase  in  blood flow resistance  manifests  itself  with  a  relative  decrease  in  end-
diastolic  velocity  resulting  in  an  increase  in  all  three  Doppler  indices.  Of  these 
indices,  the  pulsatility  index  has  the  smallest  measurement  error  and  narrower 
reference  limits.  With  extreme  increase  in  blood  flow  resistance,  end-diastolic 
forward velocity may be absent (AEDV) or reversed (REDV)32.
Table 3
Arterial Doppler Indices





systolic - end peak velocity
systolic peak velocity
Pulsatility index (PI)
systolic - end peak velocity
time averaged maximum velocity
Factors affecting the umbilical artery Doppler waveform in a normal pregnancy:
1. State of pregnancy: 
It is influenced by gestational age with advancement of pregnancy, the end- 
diastolic velocity increases and the S/D ratio declines progressively.
2. Fetal heart rate: 
With bradycardia, the diastolic phase increases and the end- diastolic velocity 
decreases  and thereby a  increase  in  the S/D ratio,  pulsatility  index and resistance 
index. Converse changes occur with tachycardia.
3. Fetal breathing:
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Doppler indices should be measured only during fetal apnea, because when the 
fetus  breathes  there  are  appreciable  changes  in  the  intrathoracic  and  central 
circulatory dynamics, which is associated with changes in the peak systolic and end 
-diastolic components of the maximum frequency shift from one cardiac cycle to the 
next.
4. Site of Doppler sampling in the cord: 
A free umbilical cord loop which is floating in amniotic fluid is examined with 
continuous or pulsed Doppler ultrasound far from the fetal and placental insertions 
(e.g., midcord segment) .If the sample is taken near the placental site lower S/D ratios 
are  obtained  and  the  highest  S/D ratios  are  obtained  if  it  is  taken  near  the  fetal 
abdominal wall.
Normal values of S/D ratio is as follows: At 20 wks  it is 7.5, at 28 wks  it 
is 5, at 34 wks it is 3.6 , at 38 wks it is 3.0, at 40 wks it is 2.8. RI > 0.72 abnormal.  
Umbilical artery doppler-sensitivity: 78% and specificity: 87% 5.
Fig 3 : Normal end diastolic flow
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Fig 4: Absent end diastolic flow
In  1983, a study by campell et al34 was the first to demonstrate a correlation 
between   pregnancies  complicated  by hypertension  and IUGR and decreased  end 
diastolic velocities in  the arcuate arteries . This finding was associated with low birth 
weight  ,  fetal  distress,  low apgar  scores  and  an  increased  caesarean  section  rate. 
Furthermore,  proteinuria  and  severe  hypertension  correlated  significantly  with 
abnormal  Doppler  indices.  Rochelson  et  al35  studied  the  extreme  umbilical  flow 
waveform abnormalities of absent or reversed diastolic flow and was the first to report 
8 perinatal  deaths  among 15 fetuses with absent end diastolic  flow. However  this 
series had also included foetuses with congenital anomalies.
Milder forms of placental vascular dysfunction, especially near term, may not 
produce  elevation  of  umbilical  artery  blood  flow  resistance  sufficiently  to  be 
detectable by traditional Doppler methods. If placental gas exchange is sufficiently 
impaired to result in perceived fetal hypoxemia, a decrease in middle cerebral artery 
Doppler resistance may occur .  Another Doppler index frequently used clinically to 
detect  this  condition  is  the  ratio  between  umbilical  artery  pulsatility  as  index  of 
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vasoconstriction  in  the  placenta  and middle  cerebral  artery pulsatility  as  index of 
vasodilation in the fetal brain. In milder forms of placental disease with near-minimal 
increase in umbilical artery blood flow resistance the cerebroplacental Doppler ratio 
(CPR) may decrease. For the umbilical artery, an abnormal test result is defined as a 
Doppler index measurement of greater than 2 SDs above the gestational age mean 
and/or  a  loss  of  end-diastolic  velocity.  Like  growth  curves,  it  is  best  to  use 
nomograms developed from a local or comparable population. For the CPR and also 
for the middle cerebral artery, a greater than 2 SD decrease of the index is considered 
abnormal.  In  a  setting  of  small  fetal  size,  these  findings  identify  those  fetuses  at 
greatest risk for adverse outcome.
Bras and Platt in 1988 and Lingman et al in36 confirmed the association of 
absent  end  diastolic  flow  with  adverse  fetal  outcome.  There  was  50%  mortality 
among 12 Patients with extreme abnormal waveforms.
A  reduction  of  umbilical  venous  blood  flow  volume  may  be  the  earliest 
Doppler sign of subtle decrease in fetal villous perfusion32 umbilical artery waveforms 
correlate with both the tertiary villous architecture and blood flow resistance. At least 
30%  of  the  fetal  villous  vasculature  is  abnormal  when  the  umbilical  artery  end 
diastolic velocities are low and resistance indices are elevated. Absence or reversal of 
umbilical  artery  end-diastolic  velocities  suggests  that  60%  to  70%  fetal  villous 
vasculature is affected33.
Placental  respiratory  function  is  related  to  the  integrity  of  the  villous 
vasculature and a decrease in arterial PO2 can trigger autoregulatory adjustments of 
vascular  smooth muscle  tone.  As diagnostic  tools,  elevated  umbilical  artery blood 




Summary of Vascular Responses in Fetuses with IUGR37
DOPPLER FINDING PHYSIOLOGIC SIGNIFICANCE
Uterine artery notching
Trophoblast  invasion  remains  limited  to  the 
myometrial  portion  of  the  spiral  arteries.  Subsequent 
failure  to  fully  transform into  a  low resistance,  high 
capacitance vascular bed increases risk for subsequent 
IUGR or  preeclampsia
Decreased, absent, or 
reversed umbilical artery 
end-diastolic velocity
Abnormal terminal villi and stem arteries result 
in  increased  placental  vascular  resistance  and  a 
proportional  decrease  in  the  umbilical  artery  end-
diastolic  velocity.  Associated  placental  perfusion 
defects are responsible for impaired feto-maternal gas 
and nutrient exchange.
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Fig 5: Middle cerebral artery-normal





The placenta is a temporary organ required for the development of the embryo 
and fetus. It allows for the exchange of metabolic products between the fetus and the 
mother.
Placental Functions 
The placenta functions in metabolism, in the transport of substances and in 
endocrine  secretion.   
Metabolism:  
During early pregnancy,  the placenta  synthesizes  glycogen,  cholesterol  and 
fatty acids, which serve as sources of nutrients and energy for the embryo and fetus.
Transport:  
The placenta has a very large surface area, which facilitates the transport of 
substances in both directions.  The surface area at 28 weeks is 5 square metres, and at 
term it is almost 11 square metres.  About 5 to 10% of this surface area is extremely 
thin, measuring only a few microns.
The bulk of the substances transferred from mother to fetus consists of oxygen 
and nutrients.  The fetus eliminates carbon dioxide and waste materials (eg., urea and 
bilirubin)  into the maternal circulation.   
The  exchange  of  gases  occurs  via  diffusion.   The  placenta  is  also  highly 
permeable  to  glucose,  but  much  less  permeable  to  fructose  and  other  common 
disaccharides.  Amino acids are transported through specfic receptors.  Some proteins 
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are transferred slowly through the placenta, mainly via pinocytosis. The transfer of 
maternal antibodies (mainly IgG) is important in providing passive immunity to the 
newborn.  Another maternal protein, transferrin, carries iron to the placental surface, 
from there it is actively transported into the fetal tissues.  Steroid hormones easily 
cross the placental barrier; protein hormones are much more poorly transported (but 
maternal thyroid hormone gains slow access to the fetus, and fetal insulin can reduce 
symptoms of maternal diabetes).  The placenta is also very permeable to alcohol and 
other drugs and to some viruses.  
Fig 7: Cross Section view of Placenta 
At the end of the pregnancy six types of villi are to be found in the placenta:
1. Stem villi 
2. Tertiary mesenchymatous villi 
3. Immature intermediate villi 
4. Mature intermediate villi 
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5. Terminal or free villi 
6. Trophoblast buds
An oxygen  tension  exists  between  maternal  deciduas  and  villous  placenta 
during embryonic development39. The stem villi guarantee the mechanical stability of 
the villus tree, the immature intermediate villi are the place of the proliferation of the 
trophoblast and the trophoblast buds. Tertiary villi (mesenchymatous) are responsible 
for the lengthening of the villus tree.
From the mature intermediate villi the free villi or terminal villi arise which 
makes up 40% of the volume and 50% of the exchange surface of the placenta before 
birth. Extravillous  trophoblast  proliferates  within  “hypoxic”  cell  columns  before 
invading the uterine stroma and the spiral arterioles39.
During  embryogenesis  the  villi  are  mainly  mesenchymal,  differentiating 
towards  immature  intermediate  villi  (Castellucci  et  al.,  1990).  They  are  poorly 
vascularised  structures,  resulting  in  high  fetoplacental  vascular  impedence:  the 
corresponding umbilical artery waveform is charecterized by AEDFV39.
Histopathological changes:
In 1995 Carolyn M. Salafia ,Victoria K. Minior 38 studied IUGR in infants less 
than 32 wks and associated pathologic features. He studied  maternal and neonatal 
charts and placental  tissues from 420 consecutive non-anomalous live born infants 
delivered at <32 wks . He observed that a greater proportion of cases with IUGR had 
lesions of uteroplacental insufficiency  or chronic viilitis than did appropriately grown 
preterm infants. The statistical relationship of most placental lesions to IUGR depends 
on the presense or absence of preeclampsia.
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In  1999  Tullia  Todros40  examined  18  placentas  from  IUGR,  preterm 
pregnancies  with pre eclampsia, 10 cases with positive end diastolic flow and eight 
with absent  diastolic  flow and compared with 6 gestational  age matched controls. 
sections  of villous  placenta  were examined.He found that  compared  with absent  / 
reverse diastolic flow, the placentas from the positive end diastolic flow showed a 
normal  pattern  of  stem  artery  development,  accompanied  by  increased  capillary 
angiogenesis  and  terminal  villous  development.  These  features  are  suggests  an 
adaptive pathway for the placenta in the fase of uteroplacental ischemia.
Gross abnormalities associated with growth restriction42:
R Weslie Tyson (2008) studied about the gross abnormalities in IUGR which 
includes decreased placental weight as compared with expected for gestational age, 
evidence  of  subacute  to  chronic  abruption  including  villous  infarction,  decidual 
necrosis,  and  staining  of  fetal  membranes  by hemosiderin;  large  space  occupying 
lesions  that  may  include  villous  infarctions,  but  also  increased  deposition  of 
intervillous fibrinoid, areas of unusual paleness that often representing loss of fetal 
vascularisation  of  chorionic  villi,  and  less  frequently  tumour  masses.  The  latter 
lesions  are  most  commonly  represented  by  chorangiomas  but  can  include 
abnormalities  of  villous  development,  such  as  hydropic  change,  mesanchymal 
dysplasia, and rarely metastatic fetal and maternal neoplasms38.
Histologic abnormalities associated with growth restriction:
The functional unit of human placenta,  the chorionic villus, goes through a 
developmental process beginning very early after conception and likely continues to 
some degree up until detachment from the uterine wall. In essence, this process takes 
large,  poorly vascularised chorionic villi  with two layers of trophoblastic elements 
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through a process of branching and vascular proliferation that later in gestation ends 
with small chorionic villi that are well vascularised with five to eight fetal capillaries 
in close approximation to the maternal blood in the intervillous space. In the mid to 
late third trimester, the separation of fetal and placental blood is only by a thin fused 
basement membrane called the vasculosyncitial membrane.
A study was undertaken at Department of pathology, Samsung cheil hospital, 
korea-clinicopathologic findings in which 45 cases with IUGR were reviewed, and 
they were compared with 24 normal control cases. The IUGR groups had significantly 
shorter mean gestational ages, lower mean placental weights, and higher incidence of 
ol;igohydramnios, compared to normal controls (P <0.05). Histologically, IUGR was 
characterised by increased incidence of  decidual vasculopathy (31.1%), multiple and 
severe infarct (P <0.05), villous fibrosis(31.1%), syncytiotrophoblastic knots (86.7%), 
and higher degree of increased perivillous fibrin deposition (P <0.05). however, there 
were  no  statistically  significant  difference  in  the  placental  lesions  between 
hypertensive and normotensive IUGR cases, except for decidual vasculopathy41.
38
Table 5  
Maternal conditions associated with growth restriction41,42,43
R Weslie Tyson (2008)
Maternal conditions Gross findings Microscopic findings
Hypertensive states
Small placenta with villous 




Large, boggy placenta but may 
be small due to poor diabetic 
control
Irregular villous maturation 




Small placenta, evidence of 
abruption,villous infarctions
Thrombi / vasculopathic 
change within uteroplacental 
vessels, villous infarction
Substance abuse Evidence of abruption
Variable with irregular villous 
development and villous 
infarction, +/- evidence of 
abruption
Sickle cell disease Small placenta
Villous ischaemic changes 
with sickle cells in intervillous 
space
High altitude 





Abnormalities of umbilical cord: It is associated with growth restriction may 
be represented  at gross level either by marginal or membranous insertion of the cord.
At both the gross and microscopic level it is important to sample the intermembranous 
or  near  membranous  vessels  to  evaluate  for  the  presence  of  organising  thrombi. 
Additionally the umbilical  cord can show abnormal  tight twisting or constrictions, 
again  leading  to  decreased  placental-fetal  exchange  leading  to  growth  restriction. 
Umbilical cord coiling index46 has been proposed as cords which are hypercoiled can 
be associated with IUGR, meconium, and fetal distress43.  Careful gross evaluation 
and selected  sampling of fetal surface vessels may show obstruction at a more distal 
level  with  organising  fibrin  thrombi  in  the  fetal  surface  vessel  or  primary 
branches,and /or hemorrhagic endovasculopathy.
Histologic  evaluation  of  fetal  membranes:  R Weslie  Tyson  et  al.,42 (2008) 
studied this and showed the following   
a. presence of meconium  indication of acute/ subacute / chronic stress
b. presence of hemosiderin  evidence of abruption
c. maternal lymphocytic infiltrate seen at the decidual or chorionic interface, 
gives a clue for non specific villitis
d. fetal membranes usually have associated maternal decidua which allows 
for the evaluation of the modified spiral arterioles - abnormalities include 
muscularised vessel wall, presence of fibrinoid necrosis with the presence 
of macrophages  seen in hypertensive states, collagen vascular diseases, 
lupus anticoagulant syndrome, and other maternal systemic illness.
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Histologic evaluation of fetal surface of placenta:
Macara et al 45 worked on the structural analysis of placental terminal villi 
from IUGR  with abnormal umbilical artery Doppler waveforms. They foundthat the 
terminal villi from IUGR cases were smaller in diameter than those controls, and had 
increased syncytial nuclei, reduced cytotrophoblastic nuclei, thickened basal lamina, 
and  increased  stromal  deposition  of  collagen  and  laminins.the  observed  major 
findings in IUGR group were presence of decidual vasculopathy, infarct, increased ST 
knots, villous fibrosis, extensive perivillous fibrin deposition.
R Weslie Tyson (2008)  his study  suggests to look for vascular abnormalities 
such as organising thrombi and lesions of hemorrhagic endovasculopathy, evidence of 
hemosiderin  deposition,  chronic  inflammation  at  chorionic  plate,   and  localised  / 
diffuse fibrinoid deposition.
Histologic evaluation of maternal surface of placenta:
R Weslie  Tyson  et  al.,  (2008)  evaluated  the  uteroplacental  vessels  for  the 
above lesions, and addiionaly there was evidence of decidual necrosis, adherent blood 
clots,  and  associated  villous  infarction  which  is  supportive  of  subacute  /  chronic 
abruption.
Histologic evaluation of chorionic villi47
R  Weslie  Tyson  et  al.,  (2008)  showed  that  gestational  age  will  alter  the 
chorionic villus morphology.  He proved  that  increased vascularisation is supportive 
of chronic  low grade underperfusion state. The  finding of mononuclear inflammation 
by maternally derived T cells is felt to be due to maternal-fetal tissue interaction and 
can recur in subsequent pregnancy in a more fulminant fashion.




Fetal and placental histologic abnormalities with growth restriction42:
Maternal conditions Gross findings Microscopic findings
Chromosomal Small / boggy placenta
Variable villous morphology 
with edema, basement 
membrane mineralisation, 





Sharing of placental 
vasculature




Dichorionic placentation with 
asymmetrical division of 
placental volume
Variable with regions of 




Variable sized placenta with 
homogenous tan parenchymal 
appearance
Increased peri and 
intervillous fibrinoid 
deposition surrounding 
largely viable chorionic villi
Chronic villitis Variable sized placenta
Mononuclear inflammation 
of chorionic villi
Intervillositis Variable sized placenta
Increased immature 
mononuclear cells within 
intervillous space
42
Macara  L.  etal45 proved that  the  defect  in  fetoplacental  vascular  perfusion 
represented  by  absent  end-diastolic  flow velocity  is  associated  with  chronic  fetal 
hypoxia,  hypercapnia,  and acidosis,  indicating a major defect in transplacental  gas 
exchange45. These observations have led to the assumption that the placenta (to be 
precise, the intervillous space and peripheral villous tree) is similarly hypoxic because 
uteroplacental blood flow is reduced46.
The appropriate response of the terminal villous network to intervillous space 
hypoxia  (for  example,  with  maternal  anemia  or  gestation  at  high  altitude)  is  an 
increase in capillarization of the terminal villi and a reduction in diffusion distance47.
Recorded  variables  from  gross  placental  examination  included  umbilical 
cordlength,insertion,  vessel  number,  and  placental  weight,  from  which  the 
fetoplacental  index  (birth  weight/placental  weight49 was  computed.  Pathological 
features were divided into seven types:  (1) ischemic changes such as hemorrhagic 
endovasculitis (HEV), perivillous fibrin deposition, villous ischemia and hemorrhage, 
and chorangiosis; (2) villous infarction and decidual necrosis; (3) chronic villitis; (4) 
abnormal villus maturity (delayed, advanced, variable, and dysmaturity); (5) placental 
abruption; (6) meconium staining; and (7) others, such as villous edema, intervillous 
thrombosis, amnion nodosum, and congested villi, after Beebe et al49. The pathologies 
were noted as present or absent, and no attempt was made to quantify the extent of the 
lesions.  Pathological  definitions  were  based  on  the  guidelines  published  by  the 
College of American Pathologists50. The data specifically examining chorioamnionitis 
and neonatal outcomes have been published previously.
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Placental Pathology and IUGR
Our  data  support  a  role  for  placental  abnormalities  in  the  development  of 
intrauterine growth restriction (IUGR)51-54,  and suggest the convergence of at least two 
pathologic developmental pathways leading to IUGR, presumably through placental 
insufficiency.  One  of  these  pathways  probably  involves  placental  ischemia  and 
placental  infarction,  leading  to  decreased  placental  perfusion.  Changes  associated 
with  decreased  placental  perfusion such  as  ischemic  changes  and those related  to 
maternal  thromboembolic  events  have  been  reported  before  in  association  with 
growth  restriction53,54.  Many  of  these  changes  are  also  associated  with  maternal 
hypertension, and it is likely that hypertensive disorders of pregnancy are associated 
with  this  pathway to  IUGR54.  Changes  of  this  nature  are  seen most  frequently  in 
fetuses  with  IUGR  who  show  abnormalities  in  umbilical  artery  Doppler 
measurements55.
Whether  villous  maturation  abnormalities  are  the  result  of  a  decrease  in 
placental  perfusion  or  somehow  share  in  its  etiology  is  not  clear,  but  these 
abnormalities may be partially explained by the presence of maternal hypertension. 
An alternative path to placental insufficiency and IUGR may involve chronic villous 
inflammation.  In  general,  5% of  cases  of  villitis  can  be  attributed  to  intrauterine 
infection,  whereas the great  majority are classified as villitis  of unknown etiology 
(VUE) 50.  In our population, this pathology was seen most frequently in the placenta 
of  IUGR  infants,  but  this  feature  was  not  related  to  the  presence  of  maternal 
hypertension,  suggesting  that  this  represents  an  independent  path  to  growth 
restriction. It may therefore be possible to subclassify and group placental pathologies 
associated with IUGR infants, as shown in the table.
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Table 7
Subclassification of Placental pathologies in IUGR (Beebe et al.,52)
Subclassification Placental findings
Vascular or ischemic 
pathology
• Vascular or ischemic pathology 
• Congested villi 
• Villous hemorrhage (intravillous) 
• Villous infarction (gross and microscopic) 
• Intervillous thrombus 
• Decidual vasculopathy 
• Decidual hemorrhage 
• Abruption 
• Fetal surface vessel/umbilical vessel thrombosis
Inflammatory 
pathology
• Villitis ( villitis of unknown etiology)
Villous maturation 
disorder
• Delayed    / Advanced




• Isolated membrane abnormality
• Amnion nodosum / Meconium deposition
• Isolated cord edema/ Isolated villous edem
• Mild peri villous fibrin deposition
45
Neonatal Outcome and Placental Pathology
Our finding of an almost 20-fold increase in the odds of dying when amnion 
nodosum  is  present  is  more  strongly  predictive  than  extreme  prematurity  in  our 
population.  Amnion nodosum tends to be associated  with oligohydramnios  arising 
from various causes50; oligohydramnios itself can be a presenting feature of placental 
insufficiency.  Whether  oligohydramnios  was  a  presenting  feature  in  those  infants 
whose placenta  exhibited  amnion  nodosum is  not  known for  our  population.  The 
significant correlation of villous edema with neonatal complications such as death, 
CLD, and IVH concurs with the findings of Redline et al.,59  who found that grade 3 
villous edema was associated with long-term neurological impairment in low birth 
weight neonates (OR 5.7;95% CI, 1.5–21.0). Villous edema, which has been linked to 
placental ischemia on the fetal side 60,  is probably associated with impaired placental 
function,  as  emphasized  by  its  correlation  with  IUGR in  our  population.  Finally, 
placental  maturity  disorders  were  associated  with  both  the  presence  of  maternal 
hypertension  and increased  odds  of  neonatal  death  and of  contracting  nosocomial 
infections. 
Chorangiosis, which has been associated with hypoxic insults to the placenta 
and adverse neonatal outcome by others61, was not associated with IUGR or adverse 
outcome in our population. However, this pathology was associated with the presence 
of maternal hypertension. Christiane Krebs62  in 1996 found that the terminal villous 
compartment  of the placenta  appears to be maldeveloped in preterm IUGR where 
absent diastolic  flow is demonstrated in the umbilical artery before delivery. These 
findings are consistent with an increase in fetoplacental  vascular impedence at the 






AIM OF THE STUDY
The placental villous dysfunction in growth restricted foetuses with abnormal 
umbilical artery blood flow is characterised by reduced elaboration of gas-exchanging 
peripheral villi, which increase the risk of chronic fetal hypoxia and acidosis.
Histologic examination of the placentas from IUGR fetuses can supplement 
clinical  knowledge  of  the  cause  of  IUGR.  The  knowledge  about  placental 
histopathology  and  its  maternal  and  fetal  implications  are  lacking  and  very  few 
studies  have  examined  the  correlation  between  Doppler  findings  and  placental 
pathology.  As  with many maternal  and fetal  conditions,  careful  evaluation  of  the 
placenta  may  aid  in  diagnosis  of  an  underlying  condition,  a  recurrent  condition, 
chromosomal abnormalities, or systemic diseases. 
The  present  study was undertaken to  analyse  the  umbilical  artery Doppler 
velocity waveforms in pregnancies complicated by intrauterine growth restriction and 






This  study  was  carried  out  in  the  antenatal  cases  who  were  booked  and 
delivered,  at  the  Department  of  Obstetrics  and  Gynaecology,  PSG  Hospitals, 
Coimbatore.  64  cases  were  enrolled  during  the  study  period  from April  2008  to 
September 2009.
INCLUSION CRITERIA: 
Singleton pregnancies complicated by IUGR identified antenatally according 
to following criteria: clinical screening / serial screening of growth - which includes 
symphysio-fundal height & abdominal palpation (fundal height which is lacking by 4 
or more weeks are included) and ultrasonographic disparity in AC >2 weeks were 
included in the study.  
EXCLUSION CRITERIA: 
1. Twin pregnancies
2. No ultrasonogram before 24 wks of gestation to confirm the gestational age 
3. Known congenital anomaly in the fetus.
METHOD OF COLLECTION OF DATA: 
In this  study,  antenatal  cases with pregnancies  complicated by IUGR were 
identified and who fulfilled the criteria mentioned above were enrolled as cases. For 
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each case, history as mentioned in the structured proforma was taken followed by a 
general, physical, systemic and obstetric examination.
Ultrasonogram was done in the cases and following parameters including fetal 
biometry, estimated fetal weight, amniotic fluid index, and doppler ultrasound of the 
umbilical  artery were noted.  The umbilical  artery waveform was measured from a 
free- floating loop of cord during fetal quiescence. The last value measured within 48 
hrs before delivery in all cases was used for this study. Based on Doppler findings the 
cases were categorised as with normal diastolic flow or reduced / absent / reversed 
end diastolic flow. 
Immediately  after  delivery,  the  newborn  is  weighed  and  the  birth  weight 
percentiles were determined by previously published normal curves by Alexander GR 
in 199663. The placentas were weighed and sent to the Department of Pathology where 
gross and histopathological examination was done by a senior pathologist.
Placental  histologic  data  examined  include  decidual  vasculopathy, 
retroplacental  hematoma,  fetal  thrombotic  arteriopathy,  chorangiosis,  acute 
inflammation,chronic deciduitis, intervillous thrombus and microcalcification. Based 
on the placental  histologic  findings  the  placental  pathology was subclassified  and 
grouped as shown in table below proposed by Beebe et al52. The placental pathology 




Fetal weight percentiles throughout Pregnancy 













20 249 275 412 772 912
21 280 314 423 790 957
22 330 376 496 826 1023
23 385 440 582 882 1107
24 435 498 674 977 1223
25 480 558 779 1138 1397
26 529 625 899 1362 1640
27 591 702 1035 1635 1927
28 670 798 1196 1977 2237
29 772 925 1394 2361 2553
30 910 1085 1637 2710 2847
31 1088 1278 1918 2986 3108
32 1294 1495 2203 3200 3338
33 1513 1725 2458 3370 3536
34 1735 1950 2667 3502 3697
35 1950 2159 2831 3596 3812
36 2156 2354 2974 3668 3888
37 2357 2541 3777 3755 3956
38 2543 2714 3263 3867 4027
39 2685 2852 3400 3980 4107
40 2761 2929 3495 4060 4185
41 2777 2948 3527 4094 4217
42 2764 2935 3522 4098 4213
43 2741 2907 3505 4096 4178
44 2724 2885 3491 4096 4122
Table 9
Subclassification of Placental pathologies in IUGR (Beebe et al.,52)
Subclassification Placental findings
Vascular or ischemic 
pathology
• Vascular or ischemic pathology 
• Congested villi 
• Villous hemorrhage (intravillous) 
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• Villous infarction (gross and microscopic) 
• Intervillous thrombus 
• Decidual vasculopathy 
• Decidual hemorrhage 
• Abruption 
• Fetal surface vessel/umbilical vessel thrombosis
Inflammatory 
pathology
• Villitis ( villitis of unknown etiology)
Villous maturation 
disorder
• Delayed    / Advanced




• Isolated membrane abnormality
• Amnion nodosum / Meconium deposition
• Isolated cord edema/ Isolated villous edem
• Mild peri villous fibrin deposition
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Method of Statistical Analysis:
The results for each parameter (numbers and percentages) for discrete data and 
averaged (mean + standard deviation) for continuous data are presented in Table and 
Figure. The Proportions were compared using Chi-square test of significance. In the 
above  test  the  “p”  value  of  less  than  0.05  was  accepted  as  indicating  statistical 
significance.  Data  analysis  was  carried  out  using  Statistical  Package  for  Social 






Total of 64 cases with IUGR were included in this study. The observations and 
results of the study are presented in the following pages.
DISTRIBUTION OF CASES BASED ON AGE:
As shown in the table, out of 64 cases the majority belong to 20-30yrs (81%) 





< 20 YRS 5 7.8%
20 – 30 YRS 52 81.3%
> 30 YRS 7 10.9%
TOTAL 64 100%
DISTRIBUTION OF CASES BASED ON GESTATIONAL AGE:










DISTRIBUTION OF CASES BASED ON ETIOLOGY:
As shown in the table, out of 64 cases, the major etiology for IUGR were PIH 
and  idiopathic  which  accounted  for  42%  each.  Other  etiologies  include  Cardiac 
disease complicating pregnancy (6%) and miscellaneous (10%).
The  miscellaneous  group  comprised  the  following  etiologies:  Connective 











DISTRIBUTION OF OLIGOHYDRAMNIOS AMONG CASES:
Oligohydramnios (<8 cms) was present in 67% of the cases as shown in the 









DISTRIBUTION OF UMBILICAL ARTERY DOPPLER WAVEFORMS IN 
CASES:
As shown in the table and pie chart, out of 64 cases, reduced end diastolic 
flow was seen in 36%, absent end diastolic flow in 34% and reversed flow in 2%. 






Reduced diastolic flow 23 35.9%
Absent diastolic flow 22 34.4%
Reverse diastolic flow 1 1.6%
Normal flow 18 28.1%
Total 64 100%
Fig 8:  Distribution of Umbilical Artery Doppler 
Waveforms
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DISTRIBUTION OF PLACENTAL PATHOLOGY IN CASES:
Among 64 cases, 34 (53.1%) cases had ischemic pathology, 9 (14.1%) had 
inflammatory,  9 (14.1%) had villous maturation disorder and 12 (18.8%) cases had 






Ischemic changes 34 53.1%





Fig 9:  Placental Pathology 
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COMPARISON  OF  UMBILICAL  ARTERY  DOPPLER  (NORMAL  AND 
ABNORMAL) WAVEFORMS WITH PLACENTAL PATHOLOGY:
Out of 64 cases, 46 cases had abnormal Doppler waveforms (reduced, absert 
and reversed diastolic flow). Among this 46 cases, 28 (60.8%) cases had ischemic 
placental  pathology,  8  (17.4%) cases  had inflammatory  pathology,  7  (15.2%) had 
maturation  disorder  and  3  (6.5%)  had  miscellaneous  placental  changes  like  mild 
perivillous fibrin deposition.
In the remaining 18 cases who had normal Doppler flow, 6 (33.3%) cases had 
ischemic placental pathology, 1 (5.5%) had inflammatory pathology, 2 (11%)  had 
maturation  disorder  and  9  (50%)  had  miscellaneous  placental  changes  like  mild 
perivillous fibrin deposition.
Ischemic, inflammatory and villous maturation disorder placental  pathologies 
were  more  commonly  observed in  cases  with  abnormal  doppler  waveforms  when 
compared  with  normal  doppler  waveforms  with  difference  being  statistically 















flow 6 (33.3%) 1 (5.5%) 2 (11%) 9 (50%)
18
(100%)
Total 34 (53%) 9 (14.1%) 9 (14.1%) 12(18.8%)
64
(100%)
Statistics DF Value Probability
Chi-Square 3 16.33 0.001
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COMPARISON  OF  ABNORMAL  UMBILICAL  ARTERY  DOPPLER 
WAVEFORMS WITH PLACENTAL PATHOLOGY:
Among 23 cases with reduced diastolic flow, majority (39.1%) had ischemic 
pathology, inflammatory, villous maturation disorder pathology accounting  for 26% 
and  21.7%  respectively  and  miscellaneous  changes  accounts  for  13%.  Similarly, 
ischemic pathology was the most predominant placental pathology in absent diastolic 
flow( 81.8%) and reverse diastolic flow ( 100%).
           In contrast, the normal Doppler waveform was more commonly associated 
with miscellaneous placental changes (50%) rather  than ischemic changes.











Reduced flow 9 (39.1%) 6 (26%) 5 (21.7%) 3 (13%) 23(100%)
Absent flow 18 (81.8%) 2 (9%) 2(9%) 0 (0%) 22(100%)
Reverse flow 1 (100%) 0 (0%) 0 (0%) 0 (0%) 1(100%)
Normal flow 6 (33.3%) 1 (5.5%) 2 (11%) 9 (50%) 18(100%)
Total 34 (53%) 9 (14.1%) 9 (14.1%) 12(18.8%)
64
(100%)
Statistics DF Value Probability
Chi-Square 9 25.5 0.002
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Fig 10:  Bar diagram showing placental pathology and umbilical artery doppler 
waveforms (X axis – doppler flow; Y axis – placental HPE changes
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Fig 11 : Normal umblical artery wave forms  
Fig 12: Reduced diastolic artery wave froms  of the umblical artery 
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Fig 13 : Gross examination of placenta showing solid yellow areas of infarction
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Fig 16 : Microscopic placental examination shows villitis of unknown etiology – 
the villi shows an inflammatory infiltrate and some of them are necrotic  (10X)
Fig 16 : High power view of the same placenta shows villitis of unknown etiology 
– there is prominent lymphocytic infiltrate in a villous. (40X)
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Fig 17: Decidual vasculopathy-fibrinoid necrosis and foam cells 
(atherosis) in decidual arterioles.
Fig 18: Decidual vasculopathy – spiral arterioles in the 
decidua have a thick muscular wall.
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Fig 19: Infarct – there is coagulation necrosis of villi
Fig 19: Villous hypoplasia -the terminal villi are of narrow caliber and filiform. 
The intervillous space appears to be expanded.
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Fig:20 Villous immaturity-the villi in this placenta are large with a reticular 
stroma and are covered by a layer of syncytiotrophoblast. Syncytiovascular 





Intrauterine  growth  restriction  is a major obstetric problem and is  associated 
with  high  perinatal  morbidity  and  mortality. Doppler assessment of the umbilical 
arterial circulation is an established test of fetal well being in pregnancy with IUGR. 
Assessment  of  placental  pathology  is  an  invaluable  tool  in  determining  the 
pathophysiology behind the growth restriction. It is also useful for determining the 
underlying mechanisms leading to pregnancy complications  and for guiding future 
investigations and interventions relating to pre-pregnancy counselling and pregnancy 
care. 
It is generally accepted that intrauterine events have an important effect  on 
neonatal mortality and the development of long-term morbidity. Therefore, placental 
examination may represent a means of investigating the intrauterine past to explain 
the present condition of the neonate. Timely examination of the placenta may even 
help  in  guiding  therapies  or  surveillance  of  infants  deemed  at  increased  risk  for 
mortality or significant morbidity. The results of this study provide new evidence for 
the  relationship  between  intrauterine  events,  reduced  fetal  growth  velocity,  and 
postnatal consequences. Specific patterns of placental pathological findings may be 
predictive of specific adverse neonatal outcomes.
In  this  study antenatal  cases  with  pregnancies  complicated  by IUGR were 
identified.  For  each  case,  ultrasonogram  was  done  in  the  cases  and  following 
parameters including fetal biometry, estimated fetal weight, amniotic fluid index, and 
Doppler ultrasound of the umbilical artery were noted. Based on Doppler findings the 
cases were categorised as with normal diastolic flow or reduced / absent / reversed 
end  diastolic  flow.  The  placentas  were  weighed  and  sent  for  histopathological 
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examination. Based on the placental histologic findings the placental pathology was 
subclassified into ischemic, inflammatory, villous maturation placental pathology and 
miscellaneous placental changes like mild perivillous fibrin deposition. The placental 
pathology  thus  identified  was  used  for  analysis  and  correlated  with  respective 
umbilical artery Doppler findings .
The observations of the study based on the chi square test reveal significant 
difference  in the placental  pathology in groups with abnormal  doppler  waveforms 
when compared with normal doppler waveforms with difference being statistically 
significant  with  p  <0.005.  An  attempt  is  made  to  discuss  the  main  findings  by 
comparing and contrasting with those of earlier studies and observations.
PLACENTAL PATHOLOGY IN CASES WITH ABNORMAL DOPPLER 
WAVEFORMS:
According  to  the  present  study,  ischemic  changes  were  the  most  common 
placental pathology accounting for 60.8% of cases with abnormal doppler waveforms. 
Inflammatory  changes  and villous  maturation  disorders  were  noted  in  17.4% and 
15.2% of cases respectively. Ischemic, inflammatory and villous maturation disorder 
placental  pathologies were more commonly observed in cases with abnormal doppler 
waveforms when compared with normal  doppler waveforms with difference being 
statistically significant with p <0.005.
The study of Krebs et  al62 on 10 placentas  of pregnancies  with IUGR and 
absent  diastolic  flow  in  umbilical  artery  also  illustrated  that  the  terminal  villous 
compartment  of  the  placenta  was  maldeveloped  with  an  increase  in  fetoplacental 
vascular impedance at the capillary level leading to ischemia and impaired gas and 
nutrient transfer in this disorder. 
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Luc Beaudet et al64 in their study on 246 placentas of IUGR pregnancies found 
that changes associated with decreased placental perfusion such as ischemic changes 
were present in more than 70% of cases. These changes were more frequently seen in 
IUGR  pregnancies  with  abnormalities  in  umbilical  artery  doppler  measurements 
similar  to  findings  of  our  study.  Villous  maturation  abnormalities  (18%)  and 
inflammatory changes (12%) were also seen in these placentas as noted in our study.
Chie-Pein Chen et al65 who examined the morphologic features of 9 placentas 
from  pregnancies  with  severe  intrauterine  fetal  growth  restriction  with  abnormal 
umbilical  artery  blood  flow  velocity  waveforms  showed  that  peripheral  villous 
vascularization was highly reduced suggestive of ischemic placental change compared 
with controls with normal umbilical artery doppler waveform.  
Tullia  Todros  et  al40  examined  18  placentas  with  IUGR in  which  10  had 
normal end diastolic flow and 8 had absent / reverse end diastolic flow. This study 
showed that placentas with absent / reverse end diastolic flow had terminal villous 
maldevelopment with ischemic changes consistent with the findings of our study.
PLACENTA PATHOLOGY IN CASES WITH NORMAL DOPPLER:
In our study, cases with IUGR with normal Doppler waveforms were more 
commonly  associated  with  miscellaneous  placental  changes  like  perivillous  fibrin 
deposition.
 Tullia  Todros  et  al40  showed that  placentas  with normal  diastolic  flow had 
changes similar to those observed in preeclampsia. This is suggestive of an adaptive 
pathway for  the  placenta  like  branching  capillary  angiogenesis  which  might  have 
occurred in the face of uteroplacental ischemia to show normal end diastolic flow.
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CONCLUSION
1. Histopathological  examination  of  placenta  in  cases  with  IUGR  revealed 
pathological  changes  like  Ischemia,  Inflammation  and  Villous  maturation 
disorders.
2. Ischemic, inflammatory and villous maturation disorder placental  pathologies 
were more commonly observed in cases with abnormal doppler waveforms 
when  compared  with  normal  doppler  waveforms  with  difference  being 
statistically significant with p <0.005. 
3. In  cases  with  abnormal  end  diastolic  flow  the  major  associated  placental 
pathology was ischemia more so with absent and reverses diastolic flow than 
reduced  diastolic  flow  with  difference  being  statistically  significant  with 
p< 0.005. 
4. In cases with IUGR with normal end diastolic flow, majority were associated 
with miscellaneous placental  changes like mild perivillous fibrin deposition 
which is of less significance. 
5. It  is  well  recognised  that  all  institutions  do  not  have  pathologist  with 
experience in doing placental pathology. If protocols are instituted such that 
placentas  from  all  cases  of  IUGR  are  subjected  to  histopathological 
examination,  it  will  allow  a  more  complete  understanding  of  the 
pathophysiology of fetal growth restriction,  knowledge of risk of additional 
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1 I08045119 1 1 0 3 0 3 3 0 0 0
2 I08045312 2 0 0 1 0 1 0 0 0 0
3 I08045275 1 0 0 0 0 0 0 0 0 0
4 I08045763 1 0 0 2 0 3 3 0 0 1
5 I08046354 1 0 0 0 1 0 1 0 0 0
6 I08046362 1 1 0 0 0 3 0 0 0 0
7 I08047140 1 0 0 1 0 0 1 0 0 0
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11 I08048704 1 0 1 0 0 3 3 0 0 0
12 I08048507 1 0 0 1 1 1 0 0 0 0
13 I08049297 2 1 1 0 0 3 3 0 0 0
14 I08049520 1 0 1 0 1 0 0 0 0 1
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29 I09008725 1 0 0 1 1 1 0 0 1 0
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30 I09008141 1 0 0 1 0 1 0 2 0 0
31 I09009742 0 0 1 0 0 3 2 2 0 0
32 I09012449 1 0 1 1 0 3 2 2 0 0
33 I09014691 1 1 0 1 0 1 0 2 0 0
34 I09015128 1 0 1 0 1 3 3 0 0 0
35 I09015473 1 0 0 0 0 3 3 2 0 0
36 I09017858 2 1 0 3 0 0 0 2 0 0
37 I09018653 1 1 1 1 1 1 0 0 0 0
38 I09020659 1 1 0 1 0 3 3 2 0 0
39 I09020951 1 1 1 0 1 0 3 2 0 0
40 I09021715 1 0 1 0 0 1 0 0 0 0
41 I09022612 0 0 0 1 0 2 0 0 0 0
42 I09022750 1 0 0 1 1 1 0 0 0 0
43 I09023496 1 1 0 1 1 0 0 2 0 0
44 I09023981 1 1 0 0 1 0 1 0 0 0
45 I09023986 1 0 0 1 0 1 0 0 0 0
46 I09027014 2 1 0 3 0 1 2 2 0 0
47 I09027736 1 1 1 2 0 0 2 2 0 0
48 I09027803 1 1 0 1 0 0 0 0 0 0
49 I09027913 1 0 1 0 1 0 0 0 0 0
50 I09027976 1 0 0 3 1 0 3 0 0 0
51 I09029468 1 0 1 0 0 3 3 2 0 0
52 I09030527 1 0 0 1 0 1 0 0 0 0
53 I09032972 1 1 0 1 0 1 0 2 0 0
54 I09032686 1 1 0 1 0 1 1 2 0 0
55 I09033663 1 0 0 1 1 1 1 2 0 0
56 I09036871 2 1 0 1 0 0 0 2 0 0
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57 I09038996 1 0 1 0 0 0 2 2 0 0
58 I09038664 1 0 0 1 0 1 0 0 0 0
59 I09038996 1 0 1 0 0 0 2 2 0 0
60 I09038554 1 1 0 0 0 0 2 2 0 0
61 I09038938 0 0 0 0 0 0 1 2 0 0
62 I09040108 2 1 1 0 0 0 1 2 0 0
63 I09042064 1 1 0 1 0 1 0 2 0 0
64 I09045890 1 1 1 0 0 0 2 2 0 0
Key to master chart : 
 1. Age   0- <20 years, 1-20 years to 30 years, 2- >30 years  
 2. Gravida 0- Primi 1-Multi 
 3. Gestation 0- Preterm 1-term
 4. Etiology 0- Idiopathic 1-PIH, 2- Cardiac, 3- Misc
 5. Oligohydramnios 0- Yes 1-No
 6. Oligohydramnios 0- Yes 1-No
 7. Doppler 0- Reduced flow 1-absent flow, 2-reversed flow, 3- Normal
 8. Placental Changes 0- ischemia 1-inflammatory, 2-villous maturation disorder, 3- Misc
 9. Mode of Delivery  0- Normal 1-Assisted, 2-LSCS
 10. Condition at birth 0- Live 1-Still birth 
 11. Birth Weight 0 <10th percentile, 1-10th to 25th percentile
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